-
For many patients, a diagnosis of cancer is the beginning of a series of stressful events. Uncertainty about long-term prognosis, changes in work and personal relationships, and the basic unpredictability of the disease compound the anxiety and discomfort associated with treatment.
-
The confusion over what constitutes effective echinacea preparations for the treatment of colds and influenza is demonstrated in several recent reviews addressing this issue.
-
Goal: To quantify the combined impact of four well-supported health behaviors on mortality in the general community.
-
-
-
In this edition of Primary Care Reports, we will only examine the role of depression and its effect on cardiovascular disease (CVD). We will also explore the recommended pharmacological approach for the treatment of depression when these two syndromes are comorbid.
-
Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
-
Disruptive behaviors are a poor prognostic sign in patients with Alzheimer's disease.
-
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.
